Hemostasis Valve Market Growth, Trends, Industry Report, 2026-2034
REPORT DETAILS
Hemostasis Valve Market Summary
The global hemostasis valve market size was valued at USD 199.66 million in 2025. The market is projected to grow at a CAGR of 6.10% from 2026 to 2034. The growth is driven by a rising number of cardiovascular and interventional procedures and growth in minimally invasive surgeries.
Market Statistics
Key Takeaways
- North America dominated with the largest share of 41.5% in 2025. The regional market dominance is driven by a high volume of cardiovascular procedures and advanced interventional healthcare infrastructure.
- The market in the U.S. is expected to witness significant growth at a 6.7% CAGR. This is due to its high healthcare spending, large aging population affected by cardiovascular diseases, and increasing adoption of minimally invasive procedures.
- Asia Pacific is projected to witness substantial growth at a 7.2% CAGR. This is primarily due to increasing healthcare investments, expanding access to minimally invasive procedures, and improving catheterization laboratory infrastructure.
- The hemostasis valve Y-connectors segment dominated with the largest share of 57.8% in 2025. The segment’s dominance is attributed to its widespread use across angioplasty, angiography, and other interventional procedures.
- The one-handed hemostasis valves segment is expected to experience significant growth at a 7.5% CAGR. This is owing to its ergonomic design, ease of operation, and enhanced procedural efficiency during catheter-based interventions.
Note: Figures and projections outlined in this report are the result of Polaris Market Research’s proprietary analytical processes, grounded in the latest available datasets and market observations.
Industry Dynamics
- The rising number of cardiovascular and interventional procedures is driving the demand for coating pretreatments.
- Growth in preference for minimally invasive surgeries is fueling the industry.
- Manufacturers are improving hemostasis valve designs to improve performance, ease of use, and patient safety.
- High cost of advanced hemostasis valves and limited access in low-resource settings restrict widespread adoption, especially in developing regions.
AI Impact on Hemostasis Valve Market
- AI enhances the process of designing hemostasis valves through analysis of performance data, as well as helping in creating dependable products.
- AI assists in quality control by detecting flaws in production and ensuring consistency in products.
- AI helps manufacturers optimize their manufacturing processes to minimize waste and increase efficiency.
- AI assists in managing inventories and predicting future demand for products.
What is Hemostasis Valve?
A hemostasis valve is a medical device used during catheter-based interventional procedures to prevent blood loss while allowing instruments to pass through vascular access sites. It typically features a sealing mechanism that maintains hemostasis when guidewires, catheters, or other devices are introduced or withdrawn. These valves are essential for maintaining a sterile field and minimizing the risk of complications such as bleeding or air embolism.
Interventional radiology and cardiology are rapidly growing medical fields due to their non-surgical, image-guided approach to diagnosing and treating diseases. These procedures involve inserting catheters into blood vessels, requiring devices that maintain hemostasis to prevent bleeding and maintain sterility. Hemostasis valves are indispensable in such procedures for controlling blood flow during device exchange. The demand for efficient, easy-to-use hemostasis valves rise as hospitals expand their interventional departments and adopt more catheter-based treatments for cancer, vascular diseases, and neurological conditions, thereby driving the growth.
Manufacturers are improving hemostasis valve designs to improve performance, ease of use, and patient safety. Newer models feature advanced sealing mechanisms, spring-actuated technology, and compatibility with a wider range of device sizes. These innovations reduce blood leakage, improve operator control, and shorten procedure time. Additionally, valves are increasingly being designed to integrate smoothly with other interventional devices and procedure packs, increasing their utility in streamlined workflows. Advanced hemostasis valves are becoming preferred choices as hospitals and clinicians seek reliable, efficient tools for complex procedures, thereby driving the growth.
Source: Polaris Market Research Analysis
Market Dynamics
Rising Number of Cardiovascular and Interventional Procedures: The growing prevalence of cardiovascular diseases, such as heart attacks, coronary artery disease, and arrhythmias, has significantly increased the number of catheter-based interventional procedures. According to the World Health Organization, in Europe alone, cardiovascular disease causes 10,000 deaths every day. Hemostasis valves play a major role in these procedures by minimizing blood loss while allowing safe passage of catheters and guidewires. The demand for minimally invasive interventions is on the rise with aging populations and sedentary lifestyles contributing to heart-related conditions globally. This, in turn, drives consistent demand for hemostasis valves as essential components in angioplasty, electrophysiology, and structural heart procedures across hospitals and specialty clinics worldwide, thereby driving the growth.
Growth in Minimally Invasive Surgeries: Minimally invasive surgeries (MIS) are gaining popularity due to their various benefits such as shorter recovery times, fewer complications, and reduced hospital stays. Procedures such as angioplasty, catheter ablation, and embolization rely heavily on catheter-based access systems where hemostasis valves are used. The demand for such valves is rising in parallel with the broader shift from traditional open surgeries to image-guided, catheter-driven techniques. The requirement for reliable vascular access management tools grows as more healthcare systems and patients opt for MIS, making them essential for safe, efficient procedural outcomes.
Growth in Neurovascular and Interventional Radiology Applications: Growth in the number of neurovascular and interventional radiology procedures performed is creating a need for hemostasis valves. Hemostasis valves are utilized in the procedure where minimally invasive methods are required for treating stroke, brain aneurysm, or other related diseases. In these procedures, doctors make use of medical devices like guidewires and catheters to access the affected part via blood vessels. Hemostasis valves allow controlling the flow of blood while providing a seal on these instruments, thus preventing any blood loss or other complications. With the preference for minimally invasive surgeries owing to quick recoveries and low risks, there will be a greater need for hemostasis valves in the coming years. An increase in the incidence rate of strokes and other neurological conditions, together with developments in neurovascular therapies, will also boost their demand.
Sustainable and Disposable Medical Device Trends: Increasingly, the healthcare industry is moving towards disposable medical devices, such as hemostasis valves, to enhance patient safety and minimize the risk of infection. The use of such devices prevents cross-contamination and eliminates the need to clean them before reuse. Convenience and consistent performance have made such disposable devices more popular among medical practitioners during catheterization and other interventions. Sustainability also remains a key issue in medical practices today. This has prompted medical device companies to take measures to become more environmentally friendly in their production processes. Medical devices made from sustainable materials, along with other measures, will gain more traction in hospitals.
Source: Polaris Market Research Analysis
Segmental Insights
Type Analysis
The segmentation, based on type, includes hemostasis valve Y- connectors, double Y- connector hemostasis valves, one- handed hemostasis valves, and others. In 2025, the hemostasis valve Y- connectors segment dominated with the largest share of 57.8% due to their widespread use in various interventional procedures. These connectors offer dual-port access, allowing simultaneous insertion of devices while effectively maintaining hemostasis, making them essential in complex cardiovascular and radiology interventions. Their compatibility with different catheter sizes and high sealing efficiency make them a preferred choice among healthcare professionals. The Y-connector’s ease of use, reliability, and integration with other vascular access tools drives their adoption, thereby driving the segment growth.
The one- handed hemostasis valves segment is expected to experience significant growth of CAGR 7.5% during the forecast period due to its ergonomic design and ease of operation. These valves allow clinicians to maintain control with a single hand during device exchanges, improving procedural efficiency and reducing the risk of blood exposure. Their user-friendly nature makes them especially useful in fast-paced environments or emergency interventions. The demand for these advanced, intuitive valves is rising as healthcare providers prioritize workflow efficiency and operator safety, thereby driving the segment growth.
Application Analysis
The segmentation, based on application, includes angiography and angioplasty. The angioplasty segment is expected to experience significant growth at a CAGR of 6.50% during the forecast period, due to its rising global use in treating blocked or narrowed arteries. The procedure relies heavily on catheters and guidewires, making hemostasis valves essential to control bleeding during device manipulation. The volume of angioplasty procedures is growing rapidly as the incidence of coronary artery disease increases worldwide. This directly boosts the demand for reliable hemostasis valves that ensure safety and efficiency throughout the procedure, thereby driving the segment growth.
End Use Analysis
The segmentation, based on end use, includes hospitals, ambulatory surgical centers, and others. In 2025, the hospitals segment dominated with the largest share of 61.0%, due to their role as primary centers for complex interventional procedures. Hospitals are equipped with advanced cath labs and interventional radiology units that routinely perform procedures requiring vascular access management. Hospitals have become the largest end users of hemostasis valves with rising patient admissions, growing adoption of minimally invasive treatments, and a preference for integrated procedure packs. Additionally, strong purchasing power and established supplier partnerships allow hospitals to maintain consistent usage, thereby driving the segment growth.
Source: Polaris Market Research Analysis
Regional Analysis
North America Hemostasis Valve Market Trend
The hemostasis valve market in North America dominated with the largest share of 41.5% in 2025, driven by a high volume of cardiovascular procedures, advanced healthcare infrastructure, and strong adoption of minimally invasive technologies. The region benefits from well-established hospitals, increased awareness of interventional care, and access to next-generation devices. Technological innovation and the presence of leading players further fuel product development and adoption. Favorable reimbursement policies and clinical training programs also support widespread use of hemostasis valves in both cardiology and radiology. The demand for reliable vascular access tools is growing as healthcare systems focus on efficiency and patient safety, thereby driving market expansion.
U.S. Hemostasis Valve Market Insight
The hemostasis valve market in the U.S. is expected to witness significant growth of CAGR 6.7% due to its high healthcare spending, advanced hospital systems, and large aging population affected by heart disease. A strong presence of key industry players and rapid integration of new technologies such as one-handed hemostasis valves contribute to its growth. The U.S. further experiences a high usage of angioplasty and catheter-based treatments, which rely heavily on hemostasis valves to manage bleeding and improve procedural outcomes. Ongoing investments in interventional care, combined with supportive regulatory frameworks and professional training, fuel the growth.
Asia Pacific Hemostasis Valve Market Analysis
The hemostasis valve market in Asia Pacific is projected to witness substantial growth of 7.2% CAGR due to increasing healthcare investments, rising cardiovascular disease cases, and expanding access to minimally invasive procedures. Countries such as China, India, Japan, and South Korea are modernizing healthcare systems, creating greater demand for advanced interventional tools. Hospitals in the region are adopting hemostasis valves more frequently with growing awareness about patient safety and cost-effective medical solutions. Additionally, the rise of local manufacturers offering affordable and compatible devices supports broader market penetration. The region’s rapid shift toward modern medical practices further fuels the growth.
China Hemostasis Valve Market Trends
The hemostasis valve market in China is expected to experience significant growth witnessing 7.80% due to its large population, increasing rates of heart disease, and strong government focus on healthcare modernization. Urban hospitals are rapidly adopting interventional cardiology procedures, and the demand for vascular access management tools such as hemostasis valves is rising accordingly. Domestic medical device manufacturers are expanding their presence, offering competitively priced, locally produced valves. Additionally, increased training of interventional specialists and growing investments in hospital infrastructure are supporting the wider use of these devices, thereby driving the growth.
Europe Hemostasis Valve Market Insight
The hemostasis valve market in Europe is expected to experience rapid growth at a CAGR of 5.0% during the forecast period, driven by advanced healthcare systems, a strong focus on patient safety, and increasing adoption of minimally invasive procedures. Countries such as Germany, the UK, France, and the Netherlands have well-established interventional cardiology and radiology practices where hemostasis valves are essential. The region further benefits from favorable regulatory frameworks and growing investments in hospital infrastructure. Rising awareness of vascular access complications and the need for efficient blood control during procedures continues to drive demand. Moreover, European medical institutions are prioritizing integrated, high-performance devices, thereby driving growth.
Source: Polaris Market Research Analysis
Key Players and Competitive Analysis
The industry is characterized by intense competition, driven by technological innovation, product differentiation, and global expansion strategies. Leading players such as Abbott, Boston Scientific Corporation, Terumo Corporation, and Merit Medical Systems dominate the market through extensive product portfolios, strong distribution networks, and ongoing R&D investments. B. Braun Melsungen AG, Teleflex Incorporated, and Nipro also hold significant market shares due to their well-established reputations and comprehensive interventional product offerings. Emerging players such as Antmed Corporation, Beijing Demax Medical Technology Co., and Lepu Medical Technology are rapidly gaining ground, particularly in Asia, by offering cost-effective and innovative valve solutions. Companies such as Argon Medical Devices, DeRoyal Industries, and Freudenberg Medical contribute niche products tailored for specific procedural needs. The market is witnessing trends toward miniaturization, improved sealing mechanisms, and integration with procedure kits, pushing manufacturers to enhance performance while meeting regulatory standards and user demand for efficiency and safety.
Key Players
- Abbott
- Antmed Corporation
- Argon Medical Devices
- B. Braun Melsungen AG
- Beijing Demax Medical Technology Co
- Boston Scientific Corporation
- DeRoyal Industries, Inc.
- Freudenberg Medical
- Lepu Medical Technology(Beijing)Co., Ltd.
- Merit Medical Systems
- Nipro
- SCW Medicath Ltd
- Teleflex Incorporated
- TERUMO CORPORATION
Industry Developments
January 2026: Curatia Medical announced the showcase of its expanded interventional portfolio at the WHX exhibition in Dubai. The highlighted products included the AutoSeal Hemostasis Valve Kit. (source: curatiamed.com)
Hemostasis Valve Market Segmentation
By Type Outlook (Revenue, USD Million, 2021–2034)
- Hemostasis Valve Y- Connectors
- Double Y- Connector Hemostasis Valves
- One- Handed Hemostasis Valves
- Others
By Application Outlook (Revenue, USD Million, 2021–2034)
- Angiography
- Angioplasty
By End Use Outlook (Revenue, USD Million, 2021–2034)
- Hospitals
- Ambulatory Surgical Centers
- Others
By Regional Outlook (Revenue, USD Million, 2021–2034)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Hemostasis Valve Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 199.66 Million |
| Market Size in 2026 | USD 210.32 Million |
| Revenue Forecast by 2034 | USD 339.88 Million |
| CAGR | 6.1% from 2026 to 2034 |
| Base Year | 2025 |
| Historical Data | 2021–2024 |
| Forecast Period | 2026–2034 |
| Quantitative Units | Revenue in USD Million and CAGR from 2026 to 2034 |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Industry Trends |
| Segments Covered |
|
| Regional Scope |
|
| Competitive Landscape |
|
| Report Format |
|
| Customization | Report customization as per your requirements with respect to countries, regions, and segmentation. |
Source: Polaris Market Research Analysis
Hemostasis Valve Market FAQ's
The global market size was valued at USD 199.66 million in 2025 and is projected to grow to USD 339.88 million by 2034.
The global market is projected to register a CAGR of 6.1% during the forecast period.
North America dominated the market with 41.5% share in 2025.
A few of the key players in the market are Abbott; Antmed Corporation; Argon Medical Devices; B. Braun Melsungen AG; Beijing Demax Medical Technology Co.; Boston Scientific Corporation; DeRoyal Industries, Inc.; Freudenberg Medical; Lepu Medical Technology (Beijing) Co., Ltd.; Merit Medical Systems; Nipro; SCW Medicath Ltd.; Teleflex Incorporated; and TERUMO CORPORATION.
The hospital segment dominated the market with 44.21% share in 2025.
The angioplasty segment is expected to witness the significant growth witnessing 6.50% CAGR during the forecast period.
Download Sample Report of Hemostasis Valve Market
Please fill out the form to request a customized copy of the research report.
